{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:43:22Z","timestamp":1773283402120,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1157\/13095372","type":"journal-article","created":{"date-parts":[[2006,12,14]],"date-time":"2006-12-14T16:33:14Z","timestamp":1166113994000},"page":"613-616","source":"Crossref","is-referenced-by-count":28,"title":["Actividad de fosfomicina sobre cepas de Escherichia coli y Klebsiella pneumoniae productoras de betalactamasas de espectro extendido"],"prefix":"10.1016","volume":"24","author":[{"given":"Marina","family":"de Cueto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 R.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"L\u00f3pez-Cerero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3n","family":"Morillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13095372_bib1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1157\/13095372_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1086\/313590","article-title":"Outbreak of multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection","volume":"30","author":"Asensio","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13095372_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1157\/13042862","article-title":"Factores de riesgo asociados con las infecciones debidas a Klebsiella pneumoniae resistentes a ceftazidima","volume":"21","author":"Bermejo","year":"2003","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13095372_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1198-743x.2001.00330.x","article-title":"Evolution and epidemiology of extended spectrum \u03b2-lactamases (ESBLs) and ESBL-producing microorganisms","volume":"7","author":"Gniadkowski","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1157\/13095372_bib5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/AAC.46.5.1481-1491.2002","article-title":"Bloodstream infection by extended spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome","volume":"46","author":"Kim","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13095372_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1157\/13042863","article-title":"Escherichia coli y Klebsiella pneumoniae productoras de betalactamasas de espectro extendido en hospitales espa\u00f1oles (proyecto GEIH-BLEE 2000)","volume":"21","author":"Hern\u00e1ndez","year":"2003","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13095372_bib7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/313719","article-title":"Epidemiology of ciprofloxacin resistance and its relationship to extended spectrum betalactamase production in Klebsiella pneumoniae isolates causing bacteremia","volume":"30","author":"Paterson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13095372_bib8","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.49.5.2137-2139.2005","article-title":"High level of antimicrobial co-resistance among extended-spectrum betalactamase-producing Enterobacteriaceae","volume":"49","author":"Schwaber","year":"2005","journal-title":"Antimicrob Agent Chemother"},{"key":"10.1157\/13095372_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1157\/13070401","article-title":"Etiolog\u00eda y sensibilidad a los antimicrobianos de los uropat\u00f3genos causantes de la infecci\u00f3n urinaria baja en la comunidad. Estudio nacional multic\u00e9ntrico","volume":"23","author":"Andreu","year":"2005","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13095372_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0924-8579(03)00230-9","article-title":"In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance","volume":"22","author":"Marchese","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1157\/13095372_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jac\/43.1.137","article-title":"Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methods","volume":"43","author":"Fuchs","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13095372_bib12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.50.1.368-370.2006","article-title":"In vitro activity of fosfomycin against extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures","volume":"50","author":"De Cueto","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1157\/13095372_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2005.01194.x","article-title":"Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum \u03b2-lactamases","volume":"11","author":"Romero","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1157\/13095372_bib14","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing 15th informational supplement. Approved standard M100-S15. Wayne: CLSI; 2005."},{"key":"10.1157\/13095372_bib15","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1128\/JCM.40.11.4030-4036.2002","article-title":"Identification and broad dissemination of the CTX-M-14 beta-lactamase in different Escherichia coli strains in the northwest area of Spain","volume":"40","author":"Bou","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13095372_bib16","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/JCM.42.3.1089-1094.2004","article-title":"Epidemiology and clinical features of infections caused by extended spectrum betalactamase producing Escherichia coli in nonhospitalized patients","volume":"42","author":"Rodr\u00edguez-Ba\u00f1o","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13095372_bib17","first-page":"77","article-title":"Escherichia coli and Klebsiella pneumoniae producing extended spectrum \u03b2-lactamases in Spain: a nationwide study","volume":"21","author":"Hern\u00e1ndez","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13095372_bib18","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1086\/421094","article-title":"Population-based laboratory surveillance for Escherichia coli-producing extended spectrum beta-lactamases. Importance of community isolates with blaCTX-M genes","volume":"38","author":"Pitout","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13095372_bib19","first-page":"303","article-title":"The current management strategies for community acquired urinary tract infection","volume":"17","author":"Hooton","year":"2003"},{"key":"10.1157\/13095372_bib20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/AAC.46.1.196-202.2002","article-title":"Occurrence of extended spectrum beta-lactamases in members of the family enterobacteriaceae in Italy: implications for resistance to \u03b2-lactams and other antimicrobial drugs","volume":"46","author":"Spanu","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13095372_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0732-8893(02)00358-9","article-title":"Potency and antimicrobial spectrum update for piperacillin\/tazobactam: emphasis on its activity against resistant organisms populations and generally untested species causing community acquired respiratory tract infections","volume":"43","author":"Johnson","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1157\/13095372_bib22","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/jac\/dkh218","article-title":"In vitro susceptibility of recent antibiotic resistant urinary pathogens to ertapenem and 12 other antibiotics","volume":"53","author":"Alhambra","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13095372_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1179\/joc.2002.14.3.237","article-title":"In vitro susceptibility of quinolone resistant clinical isolates of Escherichia coli to fosfomycin trometamol","volume":"14","author":"Ungheri","year":"2002","journal-title":"J Chemother"},{"issue":"Suppl 2","key":"10.1157\/13095372_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0924-8579(03)00231-0","article-title":"Why fosfomycin trometamol as first line therapy for uncomplicated UTI?","volume":"22","author":"Schito","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1157\/13095372_bib25","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa011265","article-title":"Widespread distribution of urinary tract infection caused by a multidrug resistant Escherichia coli clonal group","volume":"345","author":"Manges","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1157\/13095372_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/jac\/dki468","article-title":"Quinolone, fluoroquinolone, and trimethoprim-sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli","volume":"57","author":"Moreno","year":"2006","journal-title":"J Antimicrob Chemother"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X06738782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X06738782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T21:25:51Z","timestamp":1547155551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X06738782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0213005X06738782"],"URL":"https:\/\/doi.org\/10.1157\/13095372","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}